USE OF CTLA4 COMPOUND FOR ACHIEVING DRUG FREE REMISSION IN SUBJECTS WITH EARLY RA

• 收藏
• 分享

专利权人:

发明人:

KARYEKAR CHETAN

申请号：

IN201617040044

公开号：

IN201617040044A

申请日:

2016.11.23

申请国别(地区):

IN

年份:

2017

代理人:

摘要：

The present invention is directed to methods and compositions for achieving drug free remission in subjects with early RA by administering to a subject in need thereof an effective amount of soluble CTLA4 molecule until Disease Activity Score Calculator for Rheumatoid Arthritis (DAS) defined remission is achieved and then withdrawing the RA therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/